. Validation of the methodologies. Related to Figure 1 . Assessment of microglial purity after CD11b+ magnetic bead sorting by flow cytometry of GFP fluorescence in microglia isolated from the brain of wild type (A) or CX3CR1-GFP reporter (B) mice shows ~98% of GFP positive cells after microglia isolation. Density scatterplots of CX3CR1-GFP microglia incubated with isotype controls (C) or Tmem119-PacificBlue (D) show that GFP positive cells express the microglia specific marker Tmem119. Data are representative of three independent measures on n=3 individual animals/group. (E) qPCR validation: we selected a total of 26 genes (10 more expressed in males, 6 equally expressed and 10 more expressed in females). Data are expressed as 2 -ΔΔCt using the 36B4 transcript as an internal reference standard. Columns represent the mean ± s.e.m. of 6 animals per experimental group measured in triplicates. *, P < 0.05; **, P < 0,01; ***, P < 0.001 by one-way ANOVA and Tukey's method for multiple comparisons versus expression in male microglia (blue columns). The expression analyses made on the selected genes gave results superimposable with the results obtained by RNAseq (F) . . Effect on microglia of PLX3397 administration in adult C57BL/6 mice was evaluated (A) by microglia isolation and counting; (B) by qPCR analyses of C1qa gene. Data are expressed as 2 -ΔΔCt using the 36B4 transcript as an internal reference standard. Columns represent the mean ± s.e.m. of 3 animals measured in triplicates. **, P < 0.01 by two-way; ***, P < 0.001 by two-way ANOVA versus expression in microglia isolated from vehicle-treated animals; (C) by flow cytometry (representative histogram of three independent measures on n=6 individual animals/group) of GFP fluorescence in the brain of CX3CR1-GFP reporter mice treated for 7 days with vehicle (upper panel) or PLX3397 (lower panel). (D) Luciferase activity measured in extracts of microglia isolated from male G4063 mice and expressed as relative luciferase units (RLU). Dots represent the mean ± s.e.m. of 3 independent measures on n=6 individual animals/group. Brain colonization by transplanted microglia. (E) Schematic drawing of two routes of transnasal delivery of cells to the brain. After crossing the cribriform plate, the olfactory route (red arrows) divides into two branches: (1) the CSF branch and (2) the parenchymal branch. Dashed arrows represent possible hypothetical routes of cell delivery. The hypothetical trigeminal route (blue arrows) consists of at least two branches one of which crosses the cribriform plate into the parenchyma, where it diverges to the rostral and caudal parts of the brain. The second branch projects from the nasal mucosa to the trigeminal ganglion, where the exogenously applied cells are further distributed to the forebrain and caudal brain areas including the brainstem and the cerebellum. 
Microglia sorting
Adult mice were transcardially perfused with ice-cold phosphate-buffer saline (PBS), brains were dissected and washed in Hank's Balanced Salt Solution (HBSS; Life Technologies); after removing the meninges, brains from six mice were pooled as a single experimental group. Enzymatic cell dissociation was performed using Neural Tissue Dissociation Kit P (Miltenyi Biotec, Bologna, enzymatic digestion with papain, samples were dissociated mechanically, homogenized, and filtered through a 40-μm cell strainer. After extensive washes in HBSS, myelin was removed by centrifuging the dissociated brain cells, which had previously been suspended in 10 ml of cold 0.9 M sucrose solution, at 850 g and 4°C for 10 min without braking. Floating myelin and the supernatant were discarded, and cells were processed for microglia magnetic sorting by incubating with CD11b MicroBeads (diluted 1:10 in PBS + 0.05% BSA; Miltenyi Biotec) for 15 min at 4°C; after washings, cells were suspended in 500 μl of PBS + 0.05% BSA and applied to a magnetic column to purify CD11b+ cells, namely microglia. Cell counting was performed using a TC20
Automated Cell Counter (BIORAD), according to the manufacturer's protocol. Immediately after isolation of microglia, cells were processed for subsequent analyses.
PLX3397 administration
For transnasal administration mice were placed in supine position, and a heated pad was inserted under the dorsal neck to induce a hyperextension of the head back. A total of 12 μl PLX3397 (100 μg) or vehicle solution (5% DMSO + 45% PEG300 + ddH2O) was given as nose drops (3μl/drop in each nostril corresponding to 6 μl/administration), alternating between the left and right nostrils for two times, at intervals of 2 min. Subsequent doses were given each 12 h, for 1 week.
RNA preparation
RNA was purified using RNeasy minikit protocol (QIAGEN, Milan, Italy), according to the manufacturer's instructions, including a step with deoxyribonuclease incubation. RNA Quality
Control was performed on all RNA samples with an electrophoretic run on a Bioanalyzer instrument using the RNA 6000 Nano Kit (Agilent, Santa Clara, CA). RNA Integrity Number was determined for every sample and all the samples were considered suitable for processing based on the RNA integrity (RIN > 8). RNA concentration was estimated through spectrophotometric measurement using a Nanoquant Infinite M200 instrument (Tecan, Austria). Sequencing libraries were prepared using the TruSeq™ RNA Sample Preparation Kit (Illumina, San Diego, CA) using 1.8 ug of total RNA as input. Polyadenylated transcripts were purified using poly-T oligo-attached magnetic beads. PolyA RNA was fragmented at 94°C per 8 minutes and retrotranscribed using random hexamers. Multiple indexing adapters were ligated to the ends of the ds cDNA and the amount of DNA in the library was amplified with 10 PCR cycles. Final libraries were validated and quantified with the DNA1000 kit on the Agilent Bioanalyzer Instrument. Pooled libraries were sequenced on the Illumina Genome Analyzer IIx producing an average of 13 M reads per library.
Real time PCR
One μg RNA were used for cDNA preparation using 8 U/μl of Moloney murine leukemia virus reverse transcriptase (Promega, Milan, Italy) in a final volume of 25 μl; the reaction was performed at 37°C for 1 h, and the enzyme inactivated at 75°C for 5 min. Control reactions without the addition of the reverse transcription enzyme were performed (data not shown). A 1:4 cDNA dilution was amplified using GoTaq®qPCR Master Mix technology (Promega) according to the manufacturer's protocol. The PCR was carried out in triplicate on a 96-well plate using 7900HT fast real time PCR system (Applied Biosystems, Life Technologies) with the following thermal profile: 2 min at 95°C; 40 cycles, 15 sec at 95°C, 1 min at 60°C. Data were analyzed using the 2 -ΔΔCt method.
Bioinformatic analysis
BaseCall files were converted to FastQ files using Casava 1.8.2. Sequencing reads were aligned to the mouse genome (mm10) using TopHat v.2.0.9. Transcripts were reconstructed and quantified using Cufflinks v2.1.1 and differential expression analysis was performed using CuffDiff Trapnell,
2012) 31 . Cuffdiff uses the test statistics T = E[log(y)]/Var[log(y)]
, where y is the ratio of the normalized counts between two conditions. Overrepresentation analysis (ORA) on DEG lists was performed using the Functional Annotation Tool in DAVID website (https://david.ncifcrf.gov/) and Enrichr for enrichment analysis. The mouse genome was used as background list. Biological processes, molecular functions and KEGG pathways were investigated focusing on enriched terms with a Benjamini adjusted p-value less than 0.05. Transcription Factors potentially involved in the regulation of DEG were identified using the "ENCODE and ChEA Consensus TFs from ChIP-X"
database. Heatmaps and hierarchical clustering have been obtained using Genesis software.
Primer list
All mouse: Xist forward 5′-CTATCGCCCCAGGTCACATC-3′; Xist reverse, 5′-CCAGTGCAGAGGTTTTTGGC-3′; C1qa forward 5′-GACCACGGAGGCAGGGACAC-3′; C1qa
CTGCCGTCGTCTGTGCTCT-3′; Trem1 forward 5′-GTGTATCCAGCCCTCACAACT-3′; Trem1 reverse 5′-GAAGCCAAGGTGAGGAGTCC-3′; S100a9 forward 5′-AGTGTCCTCAGTTTGTGCAGAATA-3′; S100a9 reverse 5′-TGAGATGCCACACCCACTTT-3′;
Cxcl2 forward 5′-TGAACAAAGGCAAGGCTAACTGACC-3′; Cxcl2 reverse 5′- 
Luciferase enzymatic assay
Organs or cells were homogenized in Reporter Lysis Buffer (Promega, Italy) and lysates were subjected to three cycles of freezing and thawing. Proteins were separated from DNA and lysosomes by centrifugation (13000 × g for 30min), after having measured the protein concentration of the extract by the Bradford assays, the biochemical assay of Luciferase activity was carried out with a luciferase assay buffer (470 μM luciferine, 20 mM Tricine, 0.1 mM EDTA, 1.07 mM The RLU measured in WT mice were routinely subtracted from the RLU measured in the TG mice.
Magnetic Resonance Imaging Analysis
Mice were anesthetized with isofluorane (2% for induction, 1% for maintenance) in 1 L/min of O2, fixed on the holder and placed into the 6.4 cm diameter birdcage coil. A 3-orthogonal-plane, gradient echo scout acted as a geometric reference for locating the olfactory bulb. Three different DWIs were acquired using 3 orthogonal diffusion gradient directions; the reference images were identical but without diffusion gradients. Acquisition parameters were: repetition time ( 
Immunofluorescence analysis
One week after MCAO, transplanted mice were perfused with phosphate-buffered saline (PBS) and then 4% paraformaldehyde in PBS for at least 25 minutes. Brains were then removed, post-fixed 1 hour in 4% paraformaldehyde and cryoprotected in 30% sucrose solution until precipitation at 4°C.
Briefly, coronal sections of 20-µm were incubated overnight at 4°C with the primary rabbit antibody anti-Iba1 (1:30,000; Biocare Medical., USA) in PBS plus 5% normal goat serum (Dako, Denmark) and 0.1% Triton-X 100. The signal intensity was enhanced using the High Sensitivity Tyramide Signal Amplification kit and fluorescent SA-Cyanine 5 (TSA PLUS Biotin KIT; PerkinElmer, Italy) and Alexa Fluor 633-conjugated streptavidin (1:2,000; Life Technologies, Italy),
following the manufacturer's instructions. The sections were then incubated overnight at 4°C with the primary rabbit antibody anti-YM1 (1:100; StemCell Technologies, USA) and exposed for 2 hours at room temperature to goat anti-rabbit secondary antibody conjugated with Alexa Fluor 555
(1:600; Life Technologies, Italy). Nuclei were labeled with Hoechst 33258 (0.3 µg/ml; Life Technologies, Italy). For the quantitative analysis, we selected four fields of view (FOVs; 562.50 µm x 562.50 µm) surrounding the ischemic lesion, as illustrated in the drawing (Fig. 4C ). Images were acquired using a confocal microscope at 20x magnification (merge of 8-μm z-stack at 2-μm intervals) or 100x magnification (merge of 12-μm z-stack at 0.5-μm intervals, LSM510 META, Zeiss, Germany). Mean gray values of each channel were measured using ImageJ in a double-blind manner, in order to obtain a semi-quantitative evaluation of the expression of each marker.
FACS cytometry
Cell sorting experiments were performed on at least 500.000 cells for each sample by using MoFlo Astrios instrument (Beckman Coulter) equipped with 488, 546 and 640 nm lasers. For Tmem119 detection, cells were incubated 30 minutes at 4°C with Anti-TMEM119 rabbit antibody (1:500, Abcam), washed and incubated 30 minutes at 4°C with goat anti-rabbit secondary antibody conjugated with Pacific Blue (1:500, Life Technologies, Italy). Fluorescence pulses were detected using a band pass filter 531/26 nm for GFP, and 450/50 nm for Pacific Blue. Results were analyzed using Kaluza software (Beckman Coulter).
